Landscapes / Companies
Lepu Biopharma Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
5
in active trials
Trials
10 active
16 since 2021
Drugs5
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
Approved in China | Dec 2027Phase 2 trial completes | |||
| How it works | An antibody | ||||
| Next date | Dec 2027 · Phase 2 trial completes | ||||
| Also tested for | Recurrent or Metastatic Nasopharyngeal Carcinoma, Hepatocellular Carcinoma and 1 more | ||||
| Open drug page | |||||
— |
Phase 3 | Jun 2027Phase 3 trial completes | |||
| Next date | Jun 2027 · Phase 3 trial completes | ||||
| Also tested for | Advanced Pancreatic Cancer | ||||
| Open drug page | |||||
— |
Phase 3 | Aug 2027Phase 1/2 trial completes | |||
| Next date | Aug 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Recurrent or Metastatic Nasopharyngeal Carcinoma, Advanced Solid Tumors and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2027Phase 1/2 trial completes | |||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors, Hepatocellular Carcinoma | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2028Phase 1/2 trial completes | |||
| Next date | Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Colorectal Cancer | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021